this is so big that I don't think you are all getting it yet-Eileen Dannemann, so I repeat.

[Guest guest]

and what about the tylenol that is given before and after vaccines (which

depletes glutathione from liver, which is necessary for detox)?

Sheri

Dr. Yolande Lucire is in our network. She is a foresensic

psychiatrist, Phd researcher in pharmacogenetics. She basically

saved my son Dannemann who was misdiagnosed as bipolar after

experimenting with LSD at 19 years old. He was in and out of the

University of Iowa psyche ward; given drugs like Haldol, Tradazone,

Adavan....all requiring the gene Cytochrome P450 2D6 to metabolize.

For years he was being dumbed down and made incoherent until Dr. Lucire

facilitated a simple gene test (swabbing the mouth). He was indeed

missing all 2D6 activity and therefore was being poisoned and having

suicidal ideations, being arrested, thrown into the psyche wards.

He is now recovering by withdrawing all prescription drugs....thanks to

Dr. Lucire.

The interesting thing I found was that the glutathione pathway implicated

in vaccine injury/ Autism Spectrum is found on the same cytochrome

450. Vaccines are so toxic that if someone is a poor metabolizer

they will sustain a vaccine injury; then get misdiagosed as ADHD, ADD,

etc and then given harmful life debilitating drugs.

Why this is so HUGE...is because all of us know people who

are taking anti depressants, SSRIs, and ADHD medication, especially the

kids these days. Special needs education is at an all time

high!

Kids who do street drugs to experiment like did and are missing

their 2D6 activity...act so strange that invariably the parent takes them

to the Doctor and they get their own prescription. And then they get

worse, apparently more psychotic, but that is because they have no

metabolic activity. As they appear more psychotic they get more of

a cocktail of drugs and their lives go down hill. This goes for

depressed adults too.

Education and a standard of care protocol to test a person before giving

vaccines or psyche drugs has been suppressed in the medical industry and

to the public. Homicides, suicides are moving upward at an alarming

rate. Some drugs (and far from how many should be) are labled as

suicidal. That is because a substantial percentage of people who are

taking these drugs are poor metabolizers.

Look at this link and on the Mayo clinic link- as much as 50% of

the psyche drugs need 2D6 to metabolize. This is a pharma-medical

coverup of an egregious kinds. There is also a list of the drugs that

must be metabolized by 2D6.

Missing 2D6 is not a debility. I believe it is an evolutionary

issue. 30% of Tanzanian Africans have evolved to have

multiple 2D6 because they eat a lot of weeds as growing food is difficult

in that area. So they are basically eating alot of source

medication. They have become ULTRA RAPID METABOLIZERS.

Those who are found to be poor metabolizers, missing 2D6 should

not be vaccinated; should not use street or prescription drugs;

should stay away from toxic substances and eat organic food.

Notice that these are the natural attitudes of the enlightened.

Nature slam dunks the highly moral and spiritual when they stray from the

high path...I think the missing 2D6 is a corresponding physical condition

of a certain spiritual proclivity and a blessing for all those

incarnating into the greatest DRUG EPOCH in the history of mankind.

If you or your loved ones are having " apparent "

mental problems get tested. It cost only $290.00 at this time in

Australia at the lab Dr. Lucire uses. Read more on our site

about 2D6, Dr. Lucire's recent published study (riveting) on homicides

and 2D6, and the Mayo Clinic:

http://vaccineliberationarmy.com/?s=2D6

Below read about the great australian whistleblow, Dr. Yolande Lucire who

is in our network.

http://www.onlineopinion.com.au/view.asp?article=11394

ON LINE

opinion - Australia's

e-journal of social and political debate

Whistleblower in Coventry: Dr Yolande Lucire and Big

PharmaBy King

Posted Monday, 20 December 2010

Australia lags well behind the US and Britain in facing up to the

malfeasance of multinational drug companies pushing unsafe products. Very

often Big Pharma itself has largely conjured up the booming markets in

which its dubious drugs offer expensive treatment for dubious medical

conditions.

The biggest and most lucrative scandals have been in two types of

second-generation drugs: anti-depressants or SSRIs - Prozac, Paxil,

Zoloft, etc, and " atypical " antipsychotics such as Zyprexa,

Risperdal and Seroquel which were known from their licensing to be

ineffective for the vast majority of clinical trial subjects and up to

twice as bad for inducing suicide as antidepressants.

The corrupt drug trial and marketing practices of Big Pharma include

imaginary science (the serotonin deficiency theory of depression),

systematic suppression of lethal side effects (akathisia -

cannot-sit-down restlessness - leading to suicidal ideation, suicide and

murder) and a multi-billion dollar success over the past generation in

medicalising the ordinary ups and downs of the human psyche.

Feeling sad? ( " Moderate depression " , worthy of a happy little

Zoloft rock.) Diffident? ( " Social anxiety disorder " , try

Aropax.) If antidepressants cured any significant number of people there

would be significantly less cost and less demand for mental health

services in Australia. Whether from inadequate or tendentious

pharmacology training, laziness, busyness, greed driven by willed

ignorance or even misplaced conviction, the medical profession has

succumbed to the cynical marketing and the targeted blandishments of the

pharmaceutical companies.

Medical and scientific journals from Nature to The New England

Journal of Medicine allowed their columns to be infiltrated for years

by blatantly dishonest research reporting and ghost written articles

commissioned in Pharma-land but signed by distinguished professors

frequently in receipt of seven-figure research and consultancy funding.

Most of these journals do now take another tack, debunking Pharma claims

and exposing fraudulence. But many medical professional bodies are still

being subsidised beyond hope of objective dealing with the issue of mass

iatrogenesis caused by dud drugs andmultiple drug prescribing

( " polypharmacy " ), and particularly with the lethal side effects

of anti-depressants.

The key drug regulator in the US - and the planet - the United States

Food and Drug Administration (US FDA) has failed to purge the

Pharma-friendly experts who have dominated its rulings up to now. Our own

Therapeutic Goods Administration obediently follows suit, also licensing

drugs largely on information provided by their makers. But in America the

going has been getting perceptibly harder for the drug

companies.

Whistleblowers, class actions and litigious state governments confronting

ballooning health costs have been taking a toll on profits. Pfizer was

recently fined $US2.3 billion for fraudulently promoting four drugs

including the " antipsychotic " Zeldox last year. This fine is

seriously denting Pfizer's bottom (net income) line of $US8 billion, and

whistleblowers, including former Pfizer employees, collected over $US100

million for their pains in this case - a big threat to Pharma for the

future.

Although such a fine has been described in a recent British Medical

Journal as " firing 22s into the arse of a rhino " and Pfizer

has been called " too big to nail " (only a Pfizer subsidiary

pleaded guilty to criminal charges), drug companies face a rising tide of

multi-billion dollar class actions and the prospect of new laws which

could put them out of business. The original whistleblowers who were

listened to have made the key difference in the United States.

Whitaker traced the suicide epidemic and mental health cost blow-out

following the launch of Prozac in 1988. The quiet Irishman, Healy,

exposed drug trial fakery and the vast, hidden collateral damage of

pharma's SSRI bonanza in the 1990s and later.

These two and others have engineered a paradigm shift in public

understanding, and professorial heads in receipt of undeclared

consultancy riches have started to roll at research institutes and

universities in the US, including even Harvard. According to the New

York Times, Dr ph Biederman, the pioneer of " aggressive

diagnosis and drug treatment of childhood bipolar disorder " ,

failed to

report most of the $1.6 million he received in pharma funding over

several years while at Harvard.

The single person who has been trying hardest to fill the

Whitaker/Healy whistleblower gap in Australia is Sydney psychiatrist, Dr

Yolande Lucire. Thirteen years ago she began to notice alarmingly

high hospital admission and suicide rates among patients treated with

SSRIs and atypical antipsychotics in New South Wales's Greater Southern

Area Health Service. Since then she has been fighting back against the

Pharma-driven psychiatric consensus that treating with SSRIs is safe and

effective, working hard to wean patient-victims as well as their

prescribers off the drugs.

She has steadily accumulated damning statistics on suicide, homicide

and hospitalisation rates among these patients in New South Wales.

More recently it has become clear that a large percentage of people being

treated with antidepressants can't metabolise them due to common genetic

mutations. Dr Lucire has been campaigning to introduce systematic doctor

education in order to minimise promiscuous and uninformed anti-depressant

prescribing. With her complaints, findings and warnings about lack of

action, Dr Lucire has been assiduously lobbying her colleagues, the

Medical Board and the Health Care Complaints Commission of NSW, the

Adverse Drug Reactions Advisory Committee (ADRAC) of the federal

Therapeutic Goods Administration and a clutch of ministers, both state

and federal, for many years. Most recently she has been providing

redacted files on her own extensive sample of DNA swab-tested relapsing

patients suffering from the side effects of SSRIs and

polypharmacy.

And she has had one notable victory in the political arena. Under

pressure from Dr Lucire, the secretary of Health and Ageing set up an

inquiry early in 2009 into 90 of her serious adverse drug reaction

reports, which occurred mainly in normal folk treated for stress and

other vicissitudes of life and who had become suicidal and/or homicidal

on antidepressants. The Psychiatric Drug Safety Expert Advisory Panel

reported in December last year, confirming her concerns about the

near-universality of ignorant polypharmacy and dangerous gene-based

drug-drug interactions leading to akathisia, suicide and homicide and all

the mental states preceding them.But its recommendations are still

waiting to be noticed by the NSW Medical Board and Department of

Health.

So far the Medical Board seems to have quite other ideas about Dr

Lucire's contribution to public health than the Advisory Panel. In July

2007 one of the many patients she was trying to save from another bout of

potentially lethal akathisia killed her own father and sister. In her

view, this patient's akathisia was initially caused by the polypharmacy

which had previously aggravated her mental condition. But this case led

to Medical Board proceedings against her. She has concerns about the

board's procedures and why she is being targeted.

At the core of her alleged delinquency are charges that she has failed to

recognise that SSRI treatment is " standard practice " - also

" best practice " ; that she has " unusual beliefs (read: not

good for the professional bottom line) about the side effects of

psychotropic medication " ; that she is " lacking in respect for

colleagues' diagnoses " , and has been " guilty of destroying

patients " confidence in their treating doctor " (while saving

their sanity and/or lives, could we add?).

Galileo would have been familiar with this kind of stuff. What Dr

Lucire's hostile critics, like Galileo's, have not done is respond

professionally to her criticisms in scientific terms. Could they be

scared of the result? Dr Lucire continues to draw attention to the causes

of the public mental health problem, albeit at times in a naive, didactic

or exasperated manner, as she admits herself. She has good grounds for

paranoia, but she is unwise to be forever saying that no-one takes any

notice of her (fully justified) Cassandra-like warnings. The Expert

Advisory Panel did; some fair-minded journalists do, and also a

sprinkling of academics in science based disciplines.

She is appealing the latest tribunal decision in the Supreme Court of New

South Wales backed with character references by a Who's Who of people

wise to the ways of corporate money in the medical professions and

familiar with the differences between majority views and what is

scientifically established in psychiatry. Dr Lucire also persists in

trying to stymie the campaign currently building around the country to

drastically expand hospital and clinical services for the mentally

ill.

Prominent in this campaign are Australian of the Year 2010, Professor

McGorry of Melbourne University and headspace, and

Professor Ian Hickie of the Brain and Mind Research Institute at Sydney

University and the SPHERE national depression initiative.

McGorry is a proponent of early drug intervention to combat

youth depression. Ian Hickie is an outspoken and genuinely concerned

intervener in a wide array of debates on the social health of Australia

and Australians, most recently concerning the fate of badly accommodated

university students.

But his Brain and Mind Institute was lately discovered by The

Australian to be

housing Lifeblood, a private company helping the pharmacy

industry spend $75 million on " doctors' education " .

Lifeblood has boasted on its website that SPHERE, " a mental

health program undertaken by 12,000 GPs since 1998 " , of which both

Pfizer and the Brain and Mind Research Institute are commercial partners,

has restored Pfizer's Zoloft to market leadership in the anti-depressant

stakes. Hickie himself was the architect of the controversial (and

Bristol Myers Squibb funded) " depression screening tool " (a

checklist of questions for GPs) used in SPHERE.

How awkward this all must be for his institute - and for your (and my)

Sydney University, which also boasts a Pfizer/PPF Chair of Pharmacy

Management and a Pfizer Australian Chair in Clinical Pharmacy. Professor

Hickie also co-authored the Royal Australian and New Zealand College of

Psychiatrists' original (2003) recommended guidelines for treatment of

depression, whose clarion call was: " Depression is common, serious

and treatable. It affects 1 in 25 people in any 1 month. " These

RANZCP guidelines recommended that even " moderately severe "

depression should be treated with Nefazadone, a drug which was withdrawn

four months later because of fatal side effects. Very few specific side

effects or drug-drug interactions were reported in these guidelines,

which have been only cosmetically improved in their 2009 version for the

“consumer and carer”.

The RANZCP guidelines (and near identical ones around the world) emerged

from the Texas of Governor W Bush where they became mandatory in

the treatment of prisoners and public mental patients following a lavish

lobbying campaign under the rubric of the Texas Medication Algorithm

Project by Big Pharma. According to Dr Lucire, the notion of applying

algorithms or " one size fits all " to a genetically diverse

population in the days of personalised medicine borders on

obscene.

What is first and most needed in Australia's so far depressing, big

American, Pharma driven approach to depression is not more of the same

but less. Antidepressants used for anything less then severe depression,

and closely monitored, are an expensive, ineffective (less than three per

cent more effective than placebo in clinical trials presented to the US

Food and Drug Administration for their licensing) and dangerous family of

drugs whose side effects and addictive qualities have triggered a serious

crisis in public health - not least by an explosion of hospital beds for

unrecognised side effect casualties.

The highway to massive cost savings - and effective redirection of public

spending on mental health - is to break the addiction of psychiatrists,

doctors, medical bureaucracies and patients to the notion that there is a

pill for every ill. Dr Lucire's professional martyrdom may well

continue short term. But developments in the US suggest that her brave

and brilliant efforts in this direction, however casually and cynically

denigrated, will eventually prevail here. There will be many and much to

answer for if justice for her and the Australian victims of the SSRI

scourge is long delayed.

King is

convener of the West Papua Project at Sydney University and the author of

West Papua and Indonesia since Suharto: Independence, Autonomy or

Chaos? (UNSW

Press)

© The National Forum and contributors 1999-2011.

All rights reserved.

--

Best regards,

Eileen Dannemann

Director, National Coalition of Organized Women

www.ProgressiveConvergence.com

www.VaccineLiberationArmy.com

319 855-0307